Class 4 Medicines Defect Information, Rosuvastatin 5 mg, 10 mg and 20 mg film-coated tablets

Further to a previous defect notification, Accord Healthcare have informed us of an error with the patient information leaflets (PILs) that have been packaged in the below additional batches of products. These were an older version of the PIL which did not include the most up to date safety information.

MHRA drug alert date: 17 August 2022

MHRA drug alert link: https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-rosuvastatin-5-mg-10-mg-and-20-mg-film-coated-tablets-el-22-a-slash-35?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=2afcaac8-d857-4b18-9d33-b81088d65e0c&utm_content=immediately

This is a caution in use only we are not accepting stock returns - if any defective stock is found it should be returned directly to the manufacturer.

Further Information

For more information or medical information queries please contact: Accord Medical Information Department on 01271 385257, email medinfo@accord-healthcare.com.

For stock control queries, please contact: Accord Customer Services Team on 0800 373573

For updated PIL requests please contact contact@accord-healthcare.com or phone: 01271 385200